|
1
|
Zhao Z and Shilatifard A: Epigenetic modifications of histones in cancer. Genome Biol. 20(245)2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
De la Serna IL, Ohkawa Y and Imbalzano AN: Chromatin remodeling in mammalian differentiation: Lessons from ATP-dependent remodellers. Nat Rev Genet. 7:461–473. 2006.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Choudhary C, Kumar C, Gnad F, Nielsen ML, Rehman M, Walther TC, Olsen JV and Mann M: Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science. 325:834–840. 2009.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Wapenaar H and Dekker FJ: Histone acetyltransferases: Challenges in targeting bi-substrate enzymes. Clin Epigenetics. 8(59)2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Barnes PJ, Adcock IM and Ito K: Histone acetylation and deacetylation: Importance in inflammatory lung diseases. Eur Respir J. 25:552–563. 2005.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Gallinari P, Di Marco S, Jones P, Pallaoro M and Steinkühler C: HDACS, histone deacetylation and gene transcription: From molecular biology to cancer therapeutics. Cell Res. 17:195–211. 2007.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Sun XJ, Man N, Tan Y, Nimer SD and Wang L: The role of histone acetyltransferases in normal and malignant hematopoiesis. Front Oncol. 5(108)2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Bannister AJ and Kouzarides T: Regulation of chromatin by histone modifications. Cell Res. 21:381–395. 2011.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Marmorstein R and Roth SY: Histone acetyltransferases: Function, structure, and catalysis. Curr Opin Genet Dev. 11:155–161. 2001.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Pallos J, Bodai L, Lukacsovich T, Purcell JM, Steffan JS, Thompson LM and Marsh JL: Inhibition of specific HDACS and sirtuins suppresses pathogenesis in a Drosophila model of Huntington's disease. Hum Mol Genet. 17:3767–3775. 2008.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Legube G and Trouche D: Regulating histone acetyltransferases and deacetylases. EMBO Rep. 4:944–947. 2003.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Peserico A and Simone C: Physical and functional HAT/HDAC interplay regulates protein acetylation balance. J Biomed Biotechnol. 2011(371832)2011.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Tsaprouni LG, Ito K, Powell JJ, Adcock IM and Punchard N: Differential patterns of histone acetylation in inflammatory bowel diseases. J Inflamm (Lond). 8(1)2011.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Smith JA, Das A, Ray SK and Banik NL: Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res Bull. 87:10–20. 2012.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Conrad DJ, Kuhn H, Mulkins M, Highland E and Sigal E: Specific inflammatory cytokines regulate the expression of human monocyte 15-lipoxygenase. Proc Natl Acad Sci USA. 89:217–221. 1992.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Xu B, Bhattacharjee A, Roy B, Xu HM, Anthony D, Frank DA, Feldman GM and Cathcart MK: Interleukin-13 induction of 15-lipoxygenase gene expression requires p38 mitogen-activated protein kinase-mediated serine 727 phosphorylation of Stat1 and Stat3. Mol Cell Biol. 23:3918–3928. 2003.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Dhabal S, Das P, Biswas P, Kumari P, Yakubenko VP, Kundu S, Cathcart MK, Kundu M, Biswas K and Bhattacharjee A: Regulation of monoamine oxidase A (MAO-A) expression, activity, and function in IL-13-stimulated monocytes and A549 lung carcinoma cells. J Biol Chem. 293:14040–14064. 2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Beutler B and Brown T: A CAT reporter construct allows ultrasensitive estimation of TNF synthesis, and suggests that the TNF gene has been silenced in non-macrophage cell lines. J Clin Invest. 87:1336–1344. 1991.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Feng X: Regulatory roles and molecular signaling of TNF family members in osteoclasts. Gene. 350:1–13. 2005.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Parameswaran N and Patial S: Tumor necrosis factor-α signaling in macrophages. Crit Rev Eukaryot Gene Expr. 20:87–103. 2010.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Schildberger A, Rossmanith E, Eichhorn T, Strassl K and Weber V: Monocytes, peripheral blood mononuclear cells, and THP-1 cells exhibit different cytokine expression patterns following stimulation with lipopolysaccharide. Mediators Inflamm. 2013(697972)2013.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Sullivan KE, Reddy ABM, Dietzmann K, Suriano AR, Kocieda VP, Stewart M and Bhatia M: Epigenetic regulation of tumor necrosis factor alpha. Mol Cell Biol. 27:5147–5160. 2007.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Falvo JV, Tsytsykova AV and Goldfeld AE: Transcriptional control of the TNF gene. Curr Dir Autoimmun. 11:27–60. 2010.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Tsai EY, Falvo JV, Tsytsykova AV, Barczak AK, Reimold AM, Glimcher LH, Fenton MJ, Gordon DC, Dunn IF and Goldfeld AE: A lipopolysaccharide-specific enhancer complex involving Ets, Elk-1, Sp1, and CREB binding protein and p300 is recruited to the tumor necrosis factor alpha promoter in vivo. Mol Cell Biol. 20:6084–6094. 2000.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Falvo JV, Jasenosky LD, Kruidenier L and Goldfeld AE: Epigenetic control of cytokine gene expression: Regulation of the TNF/LT locus and T helper cell differentiation. Adv Immunol. 118:37–128. 2013.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Lee JY, Kim NA, Sanford A and Sullivan KE: Histone acetylation and chromatin conformation are regulated separately at the TNF-alpha promoter in monocytes and macrophages. J Leukoc Biol. 73:862–871. 2003.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Mahlknecht U, Will J, Varin A, Hoelzer D and Herbein G: Histone deacetylase 3, a class I histone deacetylase, suppresses MAPK11-mediated activating transcription factor-2 activation and represses TNF gene expression. J Immunol. 173:3979–3990. 2004.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Dumitru CD, Ceci JD, Tsatsanis C, Kontoyiannis D, Stamatakis K, Lin JH, Patriotis C, Jenkins NA, Copeland NG, Kollias G and Tsichlis PN: TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell. 103:1071–1083. 2000.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Senger K, Pham VC, Varfolomeev E, Hackney JA, Corzo CA, Collier J, Lau VWC, Huang Z, Hamidzhadeh K, Caplazi P, et al: The kinase TPL2 activates ERK and p38 signaling to promote neutrophilic inflammation. Sci Signal. 10(eaah4273)2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Huang M, Yang D, Xiang M and Wang J: Role of interleukin-6 in regulation of immune responses to remodeling after myocardial infarction. Heart Fail Rev. 20:25–38. 2015.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Scheller J, Chalaris A, Schmidt-Arras D and Rose-John S: The pro-and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta. 1813:878–888. 2011.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Schett G: Physiological effects of modulating the interleukin-6 axis. Rheumatology (Oxford). 57 (suppl_2):ii43–ii50. 2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Hu L, Yu Y, Huang H, Fan H, Hu L, Yin C, Li K, Fulton DJ and Chen F: Epigenetic regulation of interleukin 6 by histone acetylation in macrophages and its role in paraquat-induced pulmonary fibrosis. Front Immunol. 7(696)2017.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Evans PM, Zhang W, Chen X, Yang J, Bhakat KK and Liu C: Kruppel-like factor 4 is acetylated by p300 and regulates gene transcription via modulation of histone acetylation. J Biol Chem. 282:33994–34002. 2007.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Rosenzweig JM, Glenn JD, Calabresi PA and Whartenby KA: KLF4 modulates expression of IL-6 in dendritic cells via both promoter activation and epigenetic modification. J Biol Chem. 288:23868–23874. 2013.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Hou CH, Tang CH, Hsu CJ, Hou SM and Liu JF: CCN4 induces IL-6 production through αvβ5 receptor, PI3K, Akt, and NF-κB singling pathway in human synovial fibroblasts. Arthritis Res Ther. 15(R19)2013.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Yang F, Zhou S, Wang C, Huang Y, Li H, Wang Y, Zhu Z, Tang J and Yan M: Epigenetic modifications of interleukin-6 in synovial fibroblasts from osteoarthritis patients. Sci Rep. 7(43592)2017.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Makki MS and Haqqi TM: Histone deacetylase inhibitor vorinostat (SAHA, MK0683) perturb miR-9-MCPIP1 axis to block IL-1β-induced IL-6 expression in human OA chondrocytes. Connect Tissue Res. 58:64–75. 2017.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Jura J, Skalniak L and Koj A: Monocyte chemotactic protein-1-induced protein-1 (MCPIP1) is a novel multifunctional modulator of inflammatory reactions. Biochim Biophys Acta. 1823:1905–1913. 2012.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Glauben R, Sonnenberg E, Wetzel M, Mascagni P and Siegmund B: Histone deacetylase inhibitors modulate interleukin 6-dependent CD4+ T cell polarization in vitro and in vivo. J Biol Chem. 289:6142–6151. 2014.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Baker RG, Hayden MS and Ghosh S: NF-κB, inflammation, and metabolic disease. Cell Metab. 13:11–22. 2011.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Chen LF, Mu Y and Greene WC: Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB. EMBO J. 21:6539–6548. 2002.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Huang B, Yang XD, Zhou MM, Ozato K and Chen LF: Brd4 coactivates transcriptional activation of NF-kappaB via specific binding to acetylated RelA. Mol Cell Biol. 29:1375–1387. 2009.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Kiernan R, Brès V, Ng RW, Coudart MP, El Messaoudi S, Sardet C, Jin DY, Emiliani S and Benkirane M: Post-activation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65. J Biol Chem. 278:2758–2766. 2003.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Furia B, Deng L, Wu K, Baylor S, Kehn K, Li H, Donnelly R, Coleman T and Kashanchi F: Enhancement of nuclear factor-kappa B acetylation by coactivator p300 and HIV-1 Tat proteins. J Biol Chem. 277:4973–4980. 2002.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Krämer OH, Baus D, Knauer SK, Stein S, Jäger E, Stauber RH, Grez M, Pfitzner E and Heinzel T: Acetylation of Stat1 modulates NF-kappaB activity. Genes Dev. 20:473–485. 2006.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Ashburner BP, Westerheide SD and Baldwin AS Jr: The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol Cell Biol. 21:7065–7077. 2001.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Leus NG, van der Wouden PE, van den Bosch T, Hooghiemstra WTR, Ourailidou ME, Kistemaker LE, Bischoff R, Gosens R, Haisma HJ and Dekker FJ: HDAC 3-selective inhibitor RGFP966 demonstrates anti-inflammatory properties in RAW 264.7 macrophages and mouse precision-cut lung slices by attenuatiy. Biochem Pharmacol. 108:58–74. 2016.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Mahoney DJ, Cheung HH, Mrad RL, Plenchette S, Simard C, Enwere E, Arora V, Mak TW, Lacasse EC, Waring J and Korneluk RG: Both cIAP1 and cIAP2 regulate TNFalpha-mediated NF-kappaB activation. Proc Natl Acad Sci USA. 105:11778–11783. 2008.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA and Mayo MW: Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 23:2369–2380. 2004.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Michishita E, McCord RA, Berber E, Kioi M, Padilla-Nash H, Damian M, Cheung P, Kusumoto R, Kawahara TL, Barrett JC, et al: SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature. 452:492–496. 2008.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Kawahara TL, Michishita E, Adler AS, Damian M, Berber E, Lin M, mcCord RA, Ongaigui KC, Boxer LD, Chang HY and Chua KF: SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span. Cell. 136:62–74. 2009.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Varin A and Gordon S: Alternative activation of macrophages: Immune function and cellular biology. Immunobiology. 214:630–641. 2009.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Chaitidis P, O'Donnell V, Kuban RJ, Bermudez-Fajardo A, Ungethuem U and Kühn H: Gene expression alterations of human peripheral blood monocytes induced by medium-term treatment with the TH2-cytokines interleukin-4 and-13. Cytokine. 30:366–377. 2005.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Schewe T: 15-lipoxygenase-1: A prooxidant enzyme. Biol Chem. 383:365–374. 2002.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Lee YW, Kuhn H, Kaiser S, Hennig B, Daugherty A and Toborek M: Interleukin 4 induces transcription of the 15-lipoxygenase I gene in human endothelial cells. J Lipid Res. 42:783–791. 2001.PubMed/NCBI
|
|
57
|
Liu C, Xu D, Han H, Fan Y, Schain F, Xu Z, Claesson HE, Björkholm M and Sjöberg J: Transcriptional regulation of 15-lipoxygenase expression by histone h3 lysine 4 methylation/demethylation. PLoS One. 7(e52703)2012.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Çolakoğlu M, Tunçer S and Banerjee S: Emerging cellular functions of the lipid metabolizing enzyme 15-Lipoxygenase-1. Cell Prolif. 51(e12472)2018.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Moussalli MJ, Wu Y, Zuo X, Yang XL, Wistuba II, Raso MG, Morris JS, Bowser JL, Minna JD, Lotan R and Shureiqi I: Mechanistic contribution of ubiquitous 15-lipoxygenase-1 expression loss in cancer cells to terminal cell differentiation evasion. Cancer Prev Res (Phila). 4:1961–1972. 2011.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Liu C, Xu D, Sjöberg J, Forsell P, Björkholm M and Claesson HE: Transcriptional regulation of 15-lipoxygenase expression by promoter methylation. Exp Cell Res. 297:61–67. 2004.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Roy B and Cathcart MK: Induction of 15-lipoxygenase expression by IL-13 requires tyrosine phosphorylation of Jak2 and Tyk2 in human monocytes. J Biol Chem. 273:32023–32029. 1998.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Shureiqi I, Chen D, Lee JJ, Yang P, Newman RA, Brenner DE, Lotan R, Fischer SM and Lippman SM: 15-LOX-1: A novel molecular target of nonsteroidal anti-inflammatory drug-induced apoptosis in colorectal cancer cells. J Natl Cancer Inst. 92:1136–1142. 2000.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Hsi LC, Xi X, Lotan R, Shureiqi I and Lippman SM: The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells. Cancer Res. 64:8778–8781. 2004.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Shankaranarayanan P, Chaitidis P, Kühn H and Nigam S: Acetylation by histone acetyltransferase CREB-binding protein/p300 of STAT6 is required for transcriptional activation of the 15-lipoxygenase-1 gene. J Biol Chem. 276:42753–42760. 2001.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Kamitani H, Taniura S, Ikawa H, Watanabe T, Kelavkar UP and Eling TE: Expression of 15-lipoxygenase-1 is regulated by histone acetylation in human colorectal carcinoma. Carcinogenesis. 22:187–191. 2001.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Ho CF, Bon CP, Ng YK, Herr DR, Wu JS, Lin TN and Ong WY: Expression of DHA-metabolizing enzyme Alox15 is regulated by selective histone acetylation in neuroblastoma cells. Neurochem Res. 43:540–555. 2018.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Zhang C, Richon V, Ni X, Talpur R and Duvic M: Selective induction of apoptosis by histone deacetylase inhibitor SAHA in cutaneous T-cell lymphoma cells: Relevance to mechanism of therapeutic action. J Invest Dermatol. 125:1045–1052. 2005.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Zuo X, Morris JS and Shureiqi I: Chromatin modification requirements for 15-lipoxygenase-1 transcriptional reactivation in colon cancer cells. J Biol Chem. 283:31341–31347. 2008.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Shureiqi I, Jiang W, Fischer SM, Xu X, Chen D, Lee JJ, Lotan R and Lippman SM: GATA-6 transcriptional regulation of 15-lipoxygenase-1 during NSAID-induced apoptosis in colorectal cancer cells. Cancer Res. 62:1178–1183. 2002.PubMed/NCBI
|
|
70
|
Al-azzeh ED, Fegert P, Blin N and Gött P: Transcription factor GATA-6 activates expression of gastroprotective trefoil genes TFF1 and TFF2. Biochim Biophys Acta. 1490:324–332. 2000.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Akiyama Y, Watkins N, Suzuki H, Jair KW, van Engeland M, Esteller M, Sakai H, Ren CY, Yuasa Y, Herman JG and Baylin SB: GATA-4 and GATA-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric cancer. Mol Cell Biol. 23:8429–8439. 2003.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Shureiqi I, Zuo X, Broaddus R, Wu Y, Guan B, Morris JS and Lippman SM: The transcription factor GATA-6 is overexpressed in vivo and contributes to silencing 15-LOX-1 in vitro in human colon cancer. FASEB J. 21:743–753. 2007.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Guo M, Akiyama Y, House GM, Hooker CM, Heath E, Gabrielson E, Yang SC, Han Y, Baylin SB, Herman JG and Brock MV: Hypermethylation of the GATA genes in lung cancer. Clin Cancer Res. 10:7917–7924. 2004.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Kamitani H, Kameda H, Kelavkar UP and Eling TE: A GATA binding site is involved in the regulation of 15-lipoxygenase-1 expression in human colorectal carcinoma cell line, caco-2. FEBS Lett. 467:341–347. 2000.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Zuo X, Morris JS, Broaddus R and Shureiqi I: 15-LOX-1 transcription suppression via the NuRD complex in colon cancer cells. Oncogene. 28:1496–1505. 2009.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Manavathi B and Kumar R: Metastasis tumor antigens, an emerging family of multifaceted master coregulators. J Biol Chem. 282:1529–1533. 2007.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Giannini R and Cavallini A: Expression analysis of a subset of coregulators and three nuclear receptors in human colorectal carcinoma. Anticancer Res. 25:4287–4292. 2005.PubMed/NCBI
|
|
78
|
Kelavkar UP, Harya NS, Hutzley J, Bacich DJ, Monzon FA, Chandran U, Dhir R and O'Keefe DS: DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation. Prostaglandins Other Lipid Mediat. 82:185–197. 2007.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Hsi LC, Xi X, Wu Y and Lippman SM: The methyltransferase inhibitor 5-aza-2-deoxycytidine induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells. Mol Cancer Ther. 4:1740–1746. 2005.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Zuo X, Shen L, Issa JP, Moy O, Morris JS, Lippman SM and Shureiqi I: 15-Lipoxygenase-1 transcriptional silencing by DNA methyltransferase-1 independently of DNA methylation. FASEB J. 22:1981–1992. 2008.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Fuks F, Burgers WA, Brehm A, Hughes-Davies L and Kouzarides T: DNA methyltransferase Dnmt1 associates with histone deacetylase activity. Nat Genet. 24:88–91. 2000.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Grimsby J, Chen K, Wang LJ, Lan NC and Shih JC: Human monoamine oxidase A and B genes exhibit identical exon-intron organization. Proc Natl Acad Sci USA. 88:3637–3641. 1991.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Zhang J and Piantadosi C: Prevention of H2O2, generation by monoamine oxidase protects against CNS 02 toxicity. J Appl Physiol (1985). 71:1057–1061. 1991.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Cathcart MK and Bhattacharjee A: Monoamine oxidase A (MAO-A): A signature marker of alternatively activated monocytes/macrophages. Inflamm Cell Signal. 1(e161)2014.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Sosa V, Moliné T, Somoza R, Paciucci R, Kondoh H and LLeonart ME: Oxidative stress and cancer: An overview. Ageing Res Rev. 12:376–390. 2013.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Mittal M, Siddiqui MR, Tran K, Reddy SP and Malik AB: Reactive oxygen species in inflammation and tissue injury. Antioxid Redox Signal. 20:1126–1167. 2014.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Datta C and Bhattacharjee A: Role of monoamine oxidase A (MAO-A) in cardiac aging. J Cardiolcardiovasc Sci. 4:31–40. 2020.
|
|
88
|
Rybaczyk LA, Bashaw MJ, Pathak DR and Huang K: An indicator of cancer: Downregulation of monoamine oxidase-A in multiple organs and species. BMC Genomics. 9(134)2008.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Li J, Yang XM, Wang YH, Feng MX, Liu XJ, Zhang YL, Huang S, Wu Z, Xue F, Qin WX, et al: Monoamine oxidase A suppresses hepatocellular carcinoma metastasis by inhibiting the adrenergic system and its transactivation of EGFR signaling. J Hepatol. 60:1225–1234. 2014.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Hodorová I, Rybárová S, Vecanová J, Solár P, Domorákova I, Adamkov M and Mihalik J: Comparison of expression pattern of monoamine oxidase A with histopathologic subtypes and tumour grade of renal cell carcinoma. Med Sci Monit. 18:BR482–BR486. 2012.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Wu JB, Shao C, Li X, Li Q, Hu P, Shi C, Li Y, Chen YT, Yin F, Liao CP, et al: Monoamine oxidase A mediates prostate tumorigenesis and cancer metastasis. J Clin Invest. 124:2891–2908. 2014.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Bhattacharjee A, Biswas P, Dhabal S, Das P, Das P, Swaroop S, Prasad T, Dhanalakshmi J and Indhumathi S: Role of monoamine oxidase a (MAO-A) in cancer progression and metastasis. Cancer Cell Microenviron. 5(e1623)2018.
|
|
93
|
Wu JB and Shih JC: Valproic acid induces monoamine oxidase A via Akt/forkhead box O1 activation. Mol Pharmacol. 80:714–723. 2011.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Marinova Z, Ren M, Wendland JR, Leng Y, Liang MH, Yasuda S, Leeds P and Chuang DM: Valproic acid induces functional heat-shock protein 70 via Class I histone deacetylase inhibition in cortical neurons: A potential role of Sp1 acetylation. J Neurochem. 111:976–987. 2009.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Dutta P, Sabri N, Li J and Li WX: Role of STAT3 in lung cancer. JAKSTAT. 3(e999503)2015.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Khan ANH and Tomasi TB: Histone deacetylase regulation of immune gene expression in tumor cells. Immunol Res. 40:164–178. 2008.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Wu Y and Zhou BP: TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and invasion. Br J Cancer. 102:639–644. 2010.PubMed/NCBI View Article : Google Scholar
|
|
98
|
Dobreva ZG, Grigorov BG and Stanilova SA: Effect of a histone deacetylases inhibitor of IL-18 and TNF-alpha secretion in vitro. Open Access Maced J Med Sci. 6:269–273. 2018.PubMed/NCBI View Article : Google Scholar
|
|
99
|
Zhao Z, Cheng X, Wang Y, Han R, Li L, Xiang T, He L, Long H, Zhu B and He Y: Metformin inhibits the IL-6-induced epithelial-mesenchymal transition and lung adenocarcinoma growth and metastasis. PLoS One. 9(e95884)2014.PubMed/NCBI View Article : Google Scholar
|
|
100
|
Wang YC, Wu YS, Hung CY, Wang SA, Young MJ, Hsu TI and Hung JJ: USP24 induces IL-6 in tumor-associated microenvironment by stabilizing p300 and β-TrCP and promotes cancer malignancy. Nat Commun. 9(3996)2018.PubMed/NCBI View Article : Google Scholar
|
|
101
|
Sánchez-Gundín J, Fernández-Carballido AM, Martínez Valdivieso L, Barreda-Hernández D and Torres Suárez AI: New trends in the therapeutic approach to metastatic colorectal cancer. Int J Med Sci. 15:659–665. 2018.PubMed/NCBI View Article : Google Scholar
|
|
102
|
Licht JD and Bennett RL: Leveraging epigenetics to enhance the efficacy of immunotherapy. Clin Epigenetics. 13(115)2021.PubMed/NCBI View Article : Google Scholar
|
|
103
|
Wang L, Yang W, Read P, Larner J and Sheng K: Tumor cell apoptosis induced by nanoparticle conjugate in combination with radiation therapy. Nanotechnology. 21(475103)2010.PubMed/NCBI View Article : Google Scholar
|
|
104
|
Juergens RA, Wrangle J, Vendetti FP, Murphy SC, Zhao M, Coleman B, Sebree R, Rodgers K, Hooker CM, Franco N, et al: Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer. Cancer Discov. 1:598–607. 2011.PubMed/NCBI View Article : Google Scholar
|
|
105
|
Young CS, Clarke KM, Kettyle LM, Thompson A and Millis KI: Decitabine-Vorinostat combination treatment in acute myeloid leukemia activates pathways with potential for novel triple therapy. Oncotarget. 8:51429–51446. 2017.PubMed/NCBI View Article : Google Scholar
|
